JOHNSON & JOHNSON sold CVRX
February 16, 2024 · Form 4 insider transaction
JOHNSON & JOHNSON sold 3,725 shares of CVRx, Inc. at $25.81 per share, a transaction worth $96.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 19 days after the transaction.
Footnotes
On February 16, 2024, JJDC exercised the Warrant to purchase 607,725 shares of Common Stock and paid the exercise price (adjusted per the net exercise terms of the Warrant) on a cashless basis, resulting in the withholding of 3,725 of the Warrant shares to pay the exercise price and issuance to JJDC of the remaining 604,000 shares.; The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"), a wholly-owned subsidiary of Johnson & Johnson.